Written by: Mitch Evans Posted on: March 14, 2025Nexien BioPharma Inc. (NXEN): Is This Cannabinoid Stock a Hidden Gem or a Risky Bet?
Category: News
Nexien BioPharma Inc. (OTC: NXEN) is a U.S.-based pharmaceutical company focused on developing cannabinoid-based treatments within FDA-compliant pathways. Formerly known as Intiva BioPharma, the company aims to harness cannabis-derived compounds for medical applications. But with financial instability and halted R&D, does Nexien still have a…